The 13th Annual Joseph Kline Pediatric Symposium
Current Healthcare Challenges: Impacting the Future of Our Children
Cathy Butler-Witt, MA, CSW, CTTS
Assistant Director of Public Health Programs,
Southern NJ Perinatal Cooperative and
Family Health Initiatives
Diane P. Calello, MD
Medical Toxicologist, Executive
Director New Jersey Poison Information
and Education System
Attending Physician, Pediatric Emergency Medicine
Director of Medical Toxicology
Morristown Medical Center
Michelle Drzewiecka, PharmD., BCPS
Clinical Pharmacist, Capital Health
Kristina Feja, MD, MPH
Chief, Division of Pediatric Allergy,
Immunology and Infectious Diseases,
Saint Peter’s University Hospital
Consultant, Department of Pediatrics,
Edward Lifshitz, MD, FACP
Medical Director Communicable Disease Service,
NJ Department of Health and Senior Services
This program is designed to enhance the participants’ knowledge regarding current healthcare challenges impacting the future of newborns/infants/young children, school age and adolescent children, their families, healthcare providers, social workers/case managers, school administrators and nurses, and state and federal Agencies (NJ DOH, CDC, etc.). The Kline symposium provides information that supports a greater understanding of current overwhelming challenges that impact not only the future of children in New Jersey, but the future of children throughout the world.
Target audience: Pediatricians, Family Practice, Emergency Medicine, Infectious Disease, Obstetrics, Advanced Practice Nurses, Registered Nurses (Pediatric, Emergency, Infection Control, Social Work/Case Management, and School Nurses), Residents and Students (Medical School, PA’s, APNs, Nursing).
• Integrate supportive messages about the hazards of smoking into their practice.
• Develop practice-wide protocol to assess and address tobacco use with referral to cessation programs.
• Summarize the health risks associated with smoking during pregnancy, childhood exposure to secondhand and thirdhand smoke, and tobacco dependence.
• Describe the current Electronic Nicotine Delivery System (ENDS) trends.
• Classify severity and assess asthma control based on patient symptoms and spirometry values.
• Identify appropriate pharmacological treatment options for long-term control of asthma.
• Apply understanding of common asthma medication misconceptions to patient education and patient care
• Understand the epidemiology of Zika.
• Identify patients that are at risk for Zika and how to make the diagnosis.
• Review manifestations of congenital Zika virus infection.
• Discuss testing guidelines and evaluation for pregnant women and newborns.
• Discuss available “designer drugs” currently causing exposures in young adults.
• Explain the structure-function relationships which cause the clinical effects seen with exposure to these substances.
• Describe the appropriate treatment approach to patients under the influence of these compounds.
Capital Health System is an approved provider of continuing nursing education by the New Jersey State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s COA.
Program Completion Criteria: Participants need to attend entire program, and complete the program evaluation. No partial credit will be awarded.
Provider unit # P122-12/31-16.
Capital Health is accredited by the Medical Society of New Jersey to provide continuing medical education to physicians. Capital Health designates this as an AMA PRA CategoryTM . Physicians should only claim credit commensurate with the extent of their participation in the activity.
For more information, click here to view the event brochure or please contact: Margaret Estlow 609-303-4373 or Kathy Bayrasli 609-303-4513